
Neeraj Sharma
Examiner (ID: 5222, Phone: (571)270-5487 , Office: P/2659 )
| Most Active Art Unit | 2659 |
| Art Unit(s) | 2659, 2626 |
| Total Applications | 582 |
| Issued Applications | 475 |
| Pending Applications | 51 |
| Abandoned Applications | 71 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5324212
[patent_doc_number] => 20090062202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'METHODS OF TREATING AND PREVENTING PRESSURE ULCERS WITH INTRADERMAL AND TRANSDERMAL DELIVERY OF CALCITONIN GENE-RELATED PEPTIDE (CGRP)'
[patent_app_type] => utility
[patent_app_number] => 12/198110
[patent_app_country] => US
[patent_app_date] => 2008-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8358
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20090062202.pdf
[firstpage_image] =>[orig_patent_app_number] => 12198110
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/198110 | METHODS OF TREATING AND PREVENTING PRESSURE ULCERS WITH INTRADERMAL AND TRANSDERMAL DELIVERY OF CALCITONIN GENE-RELATED PEPTIDE (CGRP) | Aug 24, 2008 | Abandoned |
Array
(
[id] => 6434073
[patent_doc_number] => 20100278843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => 'AGENTS AND METHODS FOR MODULATING MACROPHAGE INHIBITORY CYTOKINE (MIC-1) ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 12/452943
[patent_app_country] => US
[patent_app_date] => 2008-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13186
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0278/20100278843.pdf
[firstpage_image] =>[orig_patent_app_number] => 12452943
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/452943 | AGENTS AND METHODS FOR MODULATING MACROPHAGE INHIBITORY CYTOKINE (MIC-1) ACTIVITY | Aug 17, 2008 | Abandoned |
Array
(
[id] => 9073892
[patent_doc_number] => 08551468
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-08
[patent_title] => 'Absorption enhancers for intranasal interferon administration'
[patent_app_type] => utility
[patent_app_number] => 12/189722
[patent_app_country] => US
[patent_app_date] => 2008-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16488
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12189722
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/189722 | Absorption enhancers for intranasal interferon administration | Aug 10, 2008 | Issued |
Array
(
[id] => 8968625
[patent_doc_number] => 08507436
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-13
[patent_title] => 'Peptides derived from plasminogen activator inhibitor-1 and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/670099
[patent_app_country] => US
[patent_app_date] => 2008-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 11102
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12670099
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/670099 | Peptides derived from plasminogen activator inhibitor-1 and uses thereof | Jul 23, 2008 | Issued |
Array
(
[id] => 4960546
[patent_doc_number] => 20080274971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'Use of ACRP30 Globular Head to Promote Increases in Muscle Mass and Muscle Differentiation'
[patent_app_type] => utility
[patent_app_number] => 12/147612
[patent_app_country] => US
[patent_app_date] => 2008-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13288
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20080274971.pdf
[firstpage_image] =>[orig_patent_app_number] => 12147612
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/147612 | Use of ACRP30 Globular Head to Promote Increases in Muscle Mass and Muscle Differentiation | Jun 26, 2008 | Abandoned |
Array
(
[id] => 5422405
[patent_doc_number] => 20090148860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'METHODS OF DIAGNOSING MUSCLE DAMAGE'
[patent_app_type] => utility
[patent_app_number] => 12/135932
[patent_app_country] => US
[patent_app_date] => 2008-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 16947
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20090148860.pdf
[firstpage_image] =>[orig_patent_app_number] => 12135932
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/135932 | METHODS OF DIAGNOSING MUSCLE DAMAGE | Jun 8, 2008 | Abandoned |
Array
(
[id] => 4740712
[patent_doc_number] => 20080234365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'NON-NUCLEAR EFFECTS OF THYROID HORMONE'
[patent_app_type] => utility
[patent_app_number] => 12/123822
[patent_app_country] => US
[patent_app_date] => 2008-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20324
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20080234365.pdf
[firstpage_image] =>[orig_patent_app_number] => 12123822
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/123822 | NON-NUCLEAR EFFECTS OF THYROID HORMONE | May 19, 2008 | Abandoned |
Array
(
[id] => 8232364
[patent_doc_number] => 08197804
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-12
[patent_title] => 'Methods for treating nervous system injury and disease'
[patent_app_type] => utility
[patent_app_number] => 12/152207
[patent_app_country] => US
[patent_app_date] => 2008-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22083
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/197/08197804.pdf
[firstpage_image] =>[orig_patent_app_number] => 12152207
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/152207 | Methods for treating nervous system injury and disease | May 12, 2008 | Issued |
Array
(
[id] => 6534592
[patent_doc_number] => 20100204101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'METHOD AND PRODUCT FOR TREATMENT AND/OR PREVENTION OF COMPLICATIONS OF PREMATURITY'
[patent_app_type] => utility
[patent_app_number] => 12/596572
[patent_app_country] => US
[patent_app_date] => 2008-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11039
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20100204101.pdf
[firstpage_image] =>[orig_patent_app_number] => 12596572
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/596572 | Method and product for treatment and/or prevention of complications of prematurity | Apr 17, 2008 | Issued |
Array
(
[id] => 4726768
[patent_doc_number] => 20080206309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'ANTAGONISTS OF PROSTAGLANDIN RECEPTORS EP2 AND/OR EP4 FOR THE TREATMENT OF DYSMENORRHEA AND MENORRHAGIA'
[patent_app_type] => utility
[patent_app_number] => 12/102554
[patent_app_country] => US
[patent_app_date] => 2008-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4157
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0206/20080206309.pdf
[firstpage_image] =>[orig_patent_app_number] => 12102554
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/102554 | ANTAGONISTS OF PROSTAGLANDIN RECEPTORS EP2 AND/OR EP4 FOR THE TREATMENT OF DYSMENORRHEA AND MENORRHAGIA | Apr 13, 2008 | Abandoned |
Array
(
[id] => 4812784
[patent_doc_number] => 20080193415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'HSA-free formulations of interferon-beta'
[patent_app_type] => utility
[patent_app_number] => 12/082177
[patent_app_country] => US
[patent_app_date] => 2008-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 12566
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20080193415.pdf
[firstpage_image] =>[orig_patent_app_number] => 12082177
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/082177 | HSA-free formulations of interferon-β | Apr 8, 2008 | Issued |
Array
(
[id] => 4739538
[patent_doc_number] => 20080233191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'USE OF RANOLAZINE FOR ELEVATED BRAIN-TYPE NATRIURETIC PEPTIDE'
[patent_app_type] => utility
[patent_app_number] => 12/052381
[patent_app_country] => US
[patent_app_date] => 2008-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5964
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20080233191.pdf
[firstpage_image] =>[orig_patent_app_number] => 12052381
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/052381 | USE OF RANOLAZINE FOR ELEVATED BRAIN-TYPE NATRIURETIC PEPTIDE | Mar 19, 2008 | Abandoned |
Array
(
[id] => 6479715
[patent_doc_number] => 20100092493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'Modulation of Complement System Activation for Treatment of Bleeding-Related Inflammation'
[patent_app_type] => utility
[patent_app_number] => 12/529980
[patent_app_country] => US
[patent_app_date] => 2008-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 23781
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20100092493.pdf
[firstpage_image] =>[orig_patent_app_number] => 12529980
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/529980 | Modulation of Complement System Activation for Treatment of Bleeding-Related Inflammation | Mar 5, 2008 | Abandoned |
Array
(
[id] => 62604
[patent_doc_number] => 07763435
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-27
[patent_title] => 'Method for diagnosis of alzheimer\'s disease with determination of LASP-1 immunoreactivity'
[patent_app_type] => utility
[patent_app_number] => 12/041370
[patent_app_country] => US
[patent_app_date] => 2008-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10139
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/763/07763435.pdf
[firstpage_image] =>[orig_patent_app_number] => 12041370
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/041370 | Method for diagnosis of alzheimer's disease with determination of LASP-1 immunoreactivity | Mar 2, 2008 | Issued |
Array
(
[id] => 5272100
[patent_doc_number] => 20090075876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Altered insulin-like growth factor binding proteins'
[patent_app_type] => utility
[patent_app_number] => 12/073134
[patent_app_country] => US
[patent_app_date] => 2008-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7546
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20090075876.pdf
[firstpage_image] =>[orig_patent_app_number] => 12073134
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/073134 | Altered insulin-like growth factor binding proteins | Feb 28, 2008 | Abandoned |
Array
(
[id] => 4764604
[patent_doc_number] => 20080175815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-24
[patent_title] => 'METHODS AND PRODUCTS FOR MODULATION OF REPRODUCTIVE PROCESSES AND FOR DIAGNOSIS, PROGNOSTICATION AND TREATMENT OR RELATED CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/036541
[patent_app_country] => US
[patent_app_date] => 2008-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 43153
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20080175815.pdf
[firstpage_image] =>[orig_patent_app_number] => 12036541
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/036541 | METHODS AND PRODUCTS FOR MODULATION OF REPRODUCTIVE PROCESSES AND FOR DIAGNOSIS, PROGNOSTICATION AND TREATMENT OR RELATED CONDITIONS | Feb 24, 2008 | Abandoned |
Array
(
[id] => 10045252
[patent_doc_number] => 09085640
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-21
[patent_title] => 'Carbamoylated EPO-Fc fusion proteins'
[patent_app_type] => utility
[patent_app_number] => 12/449639
[patent_app_country] => US
[patent_app_date] => 2008-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 5371
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12449639
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/449639 | Carbamoylated EPO-Fc fusion proteins | Feb 19, 2008 | Issued |
Array
(
[id] => 4866278
[patent_doc_number] => 20080145337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-19
[patent_title] => 'Method and pharmaceutical composition for treating inflammation'
[patent_app_type] => utility
[patent_app_number] => 12/071213
[patent_app_country] => US
[patent_app_date] => 2008-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 24013
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0145/20080145337.pdf
[firstpage_image] =>[orig_patent_app_number] => 12071213
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/071213 | Method and pharmaceutical composition for treating inflammation | Feb 18, 2008 | Abandoned |
Array
(
[id] => 6247186
[patent_doc_number] => 20100136587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'Method of Identifying Risk for Thyroid Disorder'
[patent_app_type] => utility
[patent_app_number] => 12/526129
[patent_app_country] => US
[patent_app_date] => 2008-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6698
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20100136587.pdf
[firstpage_image] =>[orig_patent_app_number] => 12526129
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/526129 | Method of Identifying Risk for Thyroid Disorder | Feb 14, 2008 | Abandoned |
Array
(
[id] => 4759925
[patent_doc_number] => 20080312151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'COMPOSITIONS AND METHODS INCLUDING EXPRESSION AND BIOACTIVITY OF BOVINE FOLLICLE STIMULATING HORMONE'
[patent_app_type] => utility
[patent_app_number] => 12/028155
[patent_app_country] => US
[patent_app_date] => 2008-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6872
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20080312151.pdf
[firstpage_image] =>[orig_patent_app_number] => 12028155
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/028155 | Methods for inducing superovulation in ungulates | Feb 7, 2008 | Issued |